腹腔镜附件手术是否需要常规预防性抗生素:多中心队列研究
该多中心回顾性队列研究纳入1,678例良性腹腔镜附件手术患者,比较切皮前头孢唑林预防与无预防对30天手术部位感染(SSI)的影响。IPTW校正后两组SSI发生率无差异(1.1% vs 1.2%,p=0.915)。手术时间≥120分钟与SSI相关(aOR 3.54,95%CI 1.41-8.85)。
要点
- 常规预防性头孢唑林未显著降低清洁腹腔镜附件手术后30天SSI发生率。
- 手术时间≥120分钟是SSI的独立危险因素(aOR 3.54)。
- 卵巢囊肿剔除亚组中举宫器使用与SSI相关(aOR 4.03)。
核心结论
- 常规预防性头孢唑林与清洁腹腔镜附件手术后30天SSI发生率显著降低无关。
- 鉴于SSI事件少且存在残余混杂可能,研究支持进一步评估选择性而非常规预防性抗生素策略。
研究设计与样本
- 多中心回顾性队列研究,使用大阪大学及六家附属医院的临床数据。
- 1,865例良性病变腹腔镜附件手术患者中,按特定排除标准后纳入1,678例。
- 根据机构政策,患者接受切皮前头孢唑林预防(n=1,415)或无预防(n=263)。
- 主要结局为术后30天内按CDC标准分类的SSI发生率。
- 采用逆概率治疗加权(IPTW)评估预防与SSI的关联,倾向评分基于年龄、BMI、糖尿病、子宫内膜异位症和腹部手术史。
主要发现
- 两组SSI发生率均为1.1%:头孢唑林组16/1,415,无抗生素组3/263。
- IPTW校正分析中,两组SSI发生率无差异(1.1% vs 1.2%;p=0.915)。
- 多变量分析中,手术时间≥120分钟与SSI相关(aOR 3.54,95%CI 1.41-8.85)。
- 卵巢囊肿剔除亚组补充分析中,举宫器使用与SSI相关(aOR 4.03,95%CI 1.26-12.90)。
临床怎么用
- 对于清洁腹腔镜附件手术,可考虑不常规使用预防性抗生素,尤其手术时间较短者。
- 手术时间≥120分钟的患者SSI风险较高,应加强围术期感染防控措施。
- 卵巢囊肿剔除术中使用举宫器可能增加SSI风险,需权衡其使用必要性。
局限性
- 回顾性队列设计,预防措施依据机构政策而非随机分配,存在残余混杂可能。
- SSI事件数较少,可能影响统计效能和结果稳定性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The benefit of routine prophylactic antibiotics for clean laparoscopic adnexal surgery remains unclear. We evaluated whether pre-incision cefazolin reduces the incidence of 30-day surgical site infections (SSIs), and we identified perioperative risk factors for SSIs. METHODS: We conducted a multicenter retrospective cohort study using clinical data from Osaka University and six affiliated hospitals. Among 1,865 patients who underwent laparoscopic adnexal surgery for benign conditions, 1,678 were included after specified exclusions. Patients received either pre-incision cefazolin (n = 1,415) or no prophylaxis (n = 263) according to institutional policy. The primary outcome was the incidence of SSI during the 30-day postoperative interval, classified according to CDC criteria. The association between prophylaxis and SSI was evaluated using inverse probability of treatment weighting (IPTW). Propensity scores were estimated using age, body mass index, diabetes mellitus, endometriosis, and previous abdominal surgery. Risk factors for SSI were assessed using multivariable logistic regression analysis. Exploratory subgroup analyses were performed by repeating the same IPTW procedure within specified subgroups, and procedure-specific supplementary analyses were performed for ovarian cystectomy. RESULTS: SSI occurred in 1.1% of patients in both groups: 16/1,415 in the cefazolin group and 3/263 in the non-antibiotic group. In IPTW-adjusted analyses, the incidence of SSI did not differ between groups (1.1% vs. 1.2%; p = 0.915). In multivariable analysis, operative time ≥120 min was associated with SSI (adjusted odds ratio [aOR] 3.54, 95% confidence interval [CI] 1.41-8.85). In supplementary analyses restricted to an ovarian cystectomy subgroup, uterine manipulator use was associated with SSI (aOR 4.03, 95% CI 1.26-12.90). CONCLUSION: Routine prophylactic cefazolin was not associated with a significantly lower incidence of 30-day SSI after clean laparoscopic adnexal surgery. Given few SSI events and the potential for residual confounding, our findings support further evaluation of a selective rather than routine approach to prophylactic antibiotic use.
引用
- Miyata H, Kobayashi E, Yasuda M, et al. Are prophylactic antibiotics routinely necessary in laparoscopic adnexal surgery? A multicenter cohort study. Surg Endosc. 2026. PMID: 42897337. doi:10.1007/s00464-026-13529-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。